comparemela.com

Latest Breaking News On - Institutional investors weigh in on titan pharmaceuticals - Page 3 : comparemela.com

Titan Pharmaceuticals (NASDAQ:TTNP) Now Covered by Analysts at StockNews com

StockNews.com initiated coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Get Rating) in a report released on Saturday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Stock Performance Titan Pharmaceuticals stock opened at $0.78 on Friday. The firm’s fifty day moving average price is $0.82 and its 200-day […]

StockNews com Begins Coverage on Titan Pharmaceuticals (NASDAQ:TTNP)

StockNews.com assumed coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Get Rating) in a research note released on Friday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Stock Performance NASDAQ:TTNP opened at $0.76 on Friday. The stock’s fifty day moving average is $0.84 and its 200 day moving average […]

Titan Pharmaceuticals (NASDAQ:TTNP) Stock Passes Below Two Hundred Day Moving Average of $0 92

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP – Get Rating) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.92 and traded as low as $0.75. Titan Pharmaceuticals shares last traded at $0.78, with a volume of 12,894 shares trading hands. Wall Street Analysts Forecast Growth Separately, StockNews.com […]

Titan Pharmaceuticals (NASDAQ:TTNP) Shares Cross Below Two Hundred Day Moving Average of $0 93

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP – Get Rating)’s stock price crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.93 and traded as low as $0.78. Titan Pharmaceuticals shares last traded at $0.80, with a volume of 17,593 shares trading hands. Wall […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.